Effects of Parachute Resistance Training in Young Athletes
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jan 28, 2024
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
The study plan consisted of three parts, a) initial evaluation testing b) implementation of a 4-week intervention training programme c) evaluation retesting.
The resisted sprint training method will be adopted. To achieve resistance, a parachute will be used. The rate of applied resistance should be such that no alteration of the running technique would be observed. Any running velocity decrease 10% compared to un-resisted running indicates that the applied resistance load is too high and will have adverse effects on the sprinting technique.
The subjects will be divided randomly into two ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 08-14 years
- • Athletic Participants will be included
- • Both Gender Boys and Girls will be included
- Exclusion Criteria:
- • Participants with any musculoskeletal, neurological, cardiovascular, or respiratory disablements
- • Those who were unable to complete follow-up tests.
- • Participants with leg length discrepancy.
- • Participants Previous surgery
- • Participants are not currently using or ever used supplements that can effect muscles
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, Punjab, Pakistan
Patients applied
Trial Officials
Umme Ammara, MS*
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported